Intravitreal injections
Intravitreal injections are a method of administering medications directly into the vitreous body of the eye. This approach is used to treat macular edema, age-related macular degeneration (AMD), diabetic retinopathy, and other serious retinal diseases.
Indications for intravitreal injections
- Age-related macular degeneration (AMD).
- Diabetic retinopathy and diabetic macular edema.
- Retinal vein occlusion associated with macular edema.
- Inflammatory eye diseases (uveitis).
- Infectious retinal diseases (cytomegalovirus retinitis).
How is the procedure performed?
- Anesthesia. Topical anesthetic eye drops are used to ensure patient comfort.
- Antiseptic preparation of the eye to minimize the risk of infection.
- Injection into the vitreous body. The medication is delivered using a very fine needle.
- Post-procedure observation. The patient remains under short-term medical supervision.
Which medications are administered intravitreally?
- Anti-VEGF agents. These inhibit abnormal blood vessel growth in AMD and diabetic retinopathy.
- Corticosteroids. Used to reduce retinal inflammation and edema.
- Antibiotics and antifungal agents. Applied in infectious retinal conditions.
Recovery after the injection
- Temporary mild discomfort or redness of the eye may occur.
- It is important to follow the ophthalmologist’s recommendations and use prescribed eye drops.
- A follow-up examination is usually scheduled within a few days after the procedure.
Advantages of intravitreal injections in Belarus
- Minimally invasive and quick procedure.
- Direct delivery of medication to the affected retinal area.
- High effectiveness in treating severe retinal diseases.
- Helps reduce the risk of irreversible vision loss.
In Belarus, intravitreal injections are performed in modern ophthalmology centers using advanced medications and up-to-date techniques. Highly qualified specialists ensure a high level of safety and treatment effectiveness.
This text has been translated using machine translation technology (DeepL API) and may contain inaccuracies.